These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26390952)

  • 61. The adverse effects of hormone replacement therapy.
    Tavani A; La Vecchia C
    Drugs Aging; 1999 May; 14(5):347-57. PubMed ID: 10408735
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Breast cancer and hormonal replacement therapy.
    Vassilopoulou-Sellin R
    Ann N Y Acad Sci; 2003 Nov; 997():341-50. PubMed ID: 14644841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening.
    Baena A; Paolino M; Villarreal-Garza C; Torres G; Delgado L; Ruiz R; Canelo-Aybar C; Song Y; Feliu A; Maza M; Jeronimo J; Espina C; Almonte M
    Cancer Epidemiol; 2023 Oct; 86 Suppl 1():102446. PubMed ID: 37852728
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.
    Bretler DM; Hansen PR; Abildstrøm SZ; Jørgensen CH; Sørensen R; Hansen ML; Schramm TK; Løkkegaard E; Torp-Pedersen C; Gislason GH
    Br J Clin Pharmacol; 2011 Jan; 71(1):105-15. PubMed ID: 21143506
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
    Gordhandas S; Norquist BM; Pennington KP; Yung RL; Laya MB; Swisher EM
    Gynecol Oncol; 2019 Apr; 153(1):192-200. PubMed ID: 30661763
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ; Taylor R; Wilcken N; Boyages J
    Eur J Cancer; 2005 Aug; 41(12):1775-81. PubMed ID: 16087330
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Maximising the use of HRT: focus on hysterectomised women.
    Keating FS; Manassiev N; Stevenson JC
    Curr Med Res Opin; 1999; 15(4):290-7. PubMed ID: 10640261
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hormone replacement therapy after surgery for epithelial ovarian cancer.
    Saeaib N; Peeyananjarassri K; Liabsuetrakul T; Buhachat R; Myriokefalitaki E
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012559. PubMed ID: 31989588
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
    Fahlén M; Fornander T; Johansson H; Johansson U; Rutqvist LE; Wilking N; von Schoultz E
    Eur J Cancer; 2013 Jan; 49(1):52-9. PubMed ID: 22892060
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66.
    Manchanda R; Gaba F; Talaulikar V; Pundir J; Gessler S; Davies M; Menon U;
    BJOG; 2022 Jan; 129(1):e16-e34. PubMed ID: 34672090
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hormone replacement therapy: the perspectives for the 21st century.
    Genazzani AR; Gambacciani M
    Maturitas; 1999 May; 32(1):11-7. PubMed ID: 10423711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
    Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hormone replacement therapy - Current recommendations.
    Vigneswaran K; Hamoda H
    Best Pract Res Clin Obstet Gynaecol; 2022 May; 81():8-21. PubMed ID: 35000809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
    Renoux C; Dell'aniello S; Garbe E; Suissa S
    BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Breast cancer and the use of the hormones around the menopause].
    Vandenbroucke JP; van Leeuwen FE; Helmerhorst FM
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1829-34. PubMed ID: 14533492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
    MacDougall LA; Barzilay JI; Helmick CG
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk of hormone replacement therapy in stroke patients.
    Damczyk MP; Gardner DM
    J Clin Pharm Ther; 2000 Aug; 25(4):239-41. PubMed ID: 10971773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.